Wednesday, July 22, 2026

NVIDIA’s Stock Takes a Dive Amid China’s Antitrust Investigation

NVIDIA's stock drops amid a Chinese antitrust probe, following allegations of failing to meet technology transfer obligations.

JLK Secures Brazil Regulatory Clearance as It Expands AI Imaging Push in Latin America

JLK accelerates its expansion into Brazil with AI medical imaging solutions, addressing rising healthcare demands for breast cancer and stroke.

‘Our GPUs Are Melting’: OpenAI Struggles to Keep Up With Viral Image Craze

OpenAI's new image-generating AI faces high demand, prompting temporary limits on image generation while improvements are made.

Dae Hyeon Moon

Author's Latest

Alzheimer’s Breakthrough: Monthly Injections of IVL3003 vs. GB-5001A—Which is More Effective?

New long-acting injectable formulations of donepezil for Alzheimer's aim to improve adherence and efficacy, easing caregiver burdens.

Celltrion’s Steqeyma IV Approval: What This Means for Celltrion’s Growth in Japan’s Autoimmune Drug Market

Celltrion's Steqeyma IV formulation gains approval in Japan, expanding treatment for Crohn's disease and enhancing market competitiveness.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Revolutionary Long-Lasting Injections: How IVL3003 and IVL3004 are Transforming Dementia and Addiction Treatments

Inventage Lab will present promising results from clinical trials of two long-acting injectables at the 2026 AAN meeting in Chicago.

Coreline Soft’s SaaS Shift: How AI is Transforming Medical Imaging in Europe and Asia

Coreline Soft shifts to a SaaS model, expanding into the European market, enhancing revenue stability, and focusing on policy integration.

Lunit supplies integrated breast cancer diagnostic solution to Lexington Clinic

Lunit supplies integrated breast cancer AI solutions to Lexington Clinic, enhancing diagnostics and expanding its presence in the Americas.

Fexuclue 40mg: How This New GERD Treatment is Revolutionizing Healthcare in Indonesia

Daewoong Pharmaceutical's Fexuclue receives approval in Indonesia for treating GERD, aiming for rapid expansion in the market.

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

Daewoong Pharmaceutical holds “Nabota Master Class,” demonstrates proprietary procedures

Daewoong Pharmaceutical hosted the "Nabota Master Class" for 74 medical professionals from 13 countries, focusing on safety and clinical application.

Wave Event: Wontech’s Strategic Push into China’s Medical Market

Wontech is expanding into China with its Wave events, showcasing certified products and building local partnerships for growth.

Hugel holds first regional symposium in Beijing, to tour key cities including Shanghai and Guangzhou

Hugel held a successful symposium in Beijing to enhance awareness of its Letybo product among Chinese medical professionals.

2026 PRP Kit Revolution: How Humedix and Medisarang Are Transforming Regenerative Medicine

Humedics and Medisarang partner to develop regenerative medicine devices, focusing on PRP kits for aesthetics and other medical fields.

Revolutionizing Patient Care: How thynC™ AI is Transforming Hospital Monitoring in 2026

ThynC technology enhances patient monitoring at Dongtan City Hospital, improving care efficiency and safety through real-time data analysis.

Celltrion sees prescription growth for key products in Europe, raises expectations for high-margin new drugs

Celltrion's cancer and autoimmune disease treatments are achieving stable growth in Europe, expanding their market influence.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.